Dr. Rabinovici’s research investigates how structural, functional and molecular brain imaging techniques can be used to improve diagnostic accuracy in dementia and to study the biology of neurodegenerative diseases, with the goal of accelerating treatment development. He leads the MAC PET imaging program and is Associate Director of the UCSF Alzheimer’s Disease Center. Dr. Rabinovici is principal investigator of Imaging Dementia: Evidence for Amyloid Scanning (IDEAS), a U.S.-wide study to assess the clinical utility of amyloid PET in 18,500 patients with MCI/dementia of uncertain etiology. He is co-PI and PET Core Director of the multi-site Longitudinal Evaluation of Early-Onset Alzheimer’s Disease Study (LEADS).
February 27, 2019
The Michigan Alzheimer’s Disease Center has invited Dr. Gil Rabinovici, to present at Neurology Grand Rounds, Wednesday, February 27th, 2019
10:30 AM to 11:30 AM
Danto Auditorium, 2nd floor of the CVC (Samuel and Jean Frankel Cardiovascular Center)